China Health Technology Group Sets Out Board and Committee Structure

China Bozza Development Holdings Limited ( (HK:1069) ) has provided an announcement.

China Health Technology Group Holding Company Limited has announced the current composition of its board of directors, naming Ms. Bu Xue as executive director, chairman and chief executive officer, alongside independent non-executive directors Mr. Chau Wing Nam and Ms. Liu Shuhua. The company also clarified the structure and membership of its three main board committees, with Mr. Chau chairing the audit, remuneration and nomination committees, and Ms. Bu and Ms. Liu serving as members, underscoring the firm’s governance framework and the role of independent oversight in its board operations.

The most recent analyst rating on (HK:1069) stock is a Hold with a HK$0.46 price target. To see the full list of analyst forecasts on China Bozza Development Holdings Limited stock, see the HK:1069 Stock Forecast page.

More about China Bozza Development Holdings Limited

China Health Technology Group Holding Company Limited is a Hong Kong-listed company (stock code: 1069) incorporated in the Cayman Islands, operating in the broader health technology sector. The company is overseen by a board comprising an executive director serving as chairman and CEO, supported by independent non-executive directors who also sit on key governance committees.

Average Trading Volume: 587,237

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$44.26M

See more data about 1069 stock on TipRanks’ Stock Analysis page.